JP2024502990A5 - - Google Patents

Info

Publication number
JP2024502990A5
JP2024502990A5 JP2023541251A JP2023541251A JP2024502990A5 JP 2024502990 A5 JP2024502990 A5 JP 2024502990A5 JP 2023541251 A JP2023541251 A JP 2023541251A JP 2023541251 A JP2023541251 A JP 2023541251A JP 2024502990 A5 JP2024502990 A5 JP 2024502990A5
Authority
JP
Japan
Prior art keywords
inventions described
inventions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023541251A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024502990A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/011448 external-priority patent/WO2022150483A1/en
Publication of JP2024502990A publication Critical patent/JP2024502990A/ja
Publication of JP2024502990A5 publication Critical patent/JP2024502990A5/ja
Pending legal-status Critical Current

Links

JP2023541251A 2021-01-06 2022-01-06 吸入可能なイマチニブ製剤 Pending JP2024502990A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163134336P 2021-01-06 2021-01-06
US63/134,336 2021-01-06
US202163170246P 2021-04-02 2021-04-02
US63/170,246 2021-04-02
PCT/US2022/011448 WO2022150483A1 (en) 2021-01-06 2022-01-06 Inhalable imatinib formulation

Publications (2)

Publication Number Publication Date
JP2024502990A JP2024502990A (ja) 2024-01-24
JP2024502990A5 true JP2024502990A5 (cg-RX-API-DMAC7.html) 2025-01-15

Family

ID=82357645

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023541251A Pending JP2024502990A (ja) 2021-01-06 2022-01-06 吸入可能なイマチニブ製剤

Country Status (6)

Country Link
US (1) US20220241278A1 (cg-RX-API-DMAC7.html)
EP (1) EP4274577A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024502990A (cg-RX-API-DMAC7.html)
AU (1) AU2022205940A1 (cg-RX-API-DMAC7.html)
CA (1) CA3204054A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022150483A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024015518A1 (en) * 2022-07-13 2024-01-18 Inaya Therapeutics, Inc. Inhalable imatinib formulation
EP4311539A1 (en) * 2022-07-29 2024-01-31 Artorange Ltd. Imatinib formulation for parenteral administration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060128653A1 (en) * 2004-12-10 2006-06-15 Chunlin Tang Pharmaceutical formulation of decitabine
PL2305263T3 (pl) * 2007-06-07 2012-12-31 Novartis Ag Stabilizowane amorficzne formy mesylanu imatinibu
CN102008734A (zh) * 2010-12-02 2011-04-13 深圳海王药业有限公司 一种α晶型伊马替尼的包合物及其制备方法
US20150182490A1 (en) * 2012-06-26 2015-07-02 Del Mar Pharmaceuticals Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof
CA3280124A1 (en) * 2013-07-31 2025-10-31 Avalyn Pharma Inc. Aerosol imatinib compounds and uses thereof
US11413289B2 (en) * 2019-05-16 2022-08-16 Aerovate Therapeutics, Inc. Inhalable imatinib formulations, manufacture, and uses thereof

Similar Documents

Publication Publication Date Title
JP2023085489A5 (cg-RX-API-DMAC7.html)
JP2023105131A5 (cg-RX-API-DMAC7.html)
JP2022068302A5 (cg-RX-API-DMAC7.html)
JP2021151238A5 (cg-RX-API-DMAC7.html)
JP2023116721A5 (cg-RX-API-DMAC7.html)
JP2023052878A5 (cg-RX-API-DMAC7.html)
JP2023022224A5 (cg-RX-API-DMAC7.html)
JP2021048879A5 (cg-RX-API-DMAC7.html)
JP2024016014A5 (cg-RX-API-DMAC7.html)
JP2025506484A5 (cg-RX-API-DMAC7.html)
JP2023100643A5 (cg-RX-API-DMAC7.html)
JP2022060295A5 (cg-RX-API-DMAC7.html)
JP2021100406A5 (cg-RX-API-DMAC7.html)
JP2022544380A5 (cg-RX-API-DMAC7.html)
JP2021129286A5 (cg-RX-API-DMAC7.html)
JP2024507827A5 (cg-RX-API-DMAC7.html)
JP2024534771A5 (cg-RX-API-DMAC7.html)
JP2023011759A5 (cg-RX-API-DMAC7.html)
JP2023041070A5 (cg-RX-API-DMAC7.html)
JP2020141705A5 (cg-RX-API-DMAC7.html)
JP2022122912A5 (cg-RX-API-DMAC7.html)
JP2025138639A5 (cg-RX-API-DMAC7.html)
JP2023182736A5 (cg-RX-API-DMAC7.html)
JP2026004274A5 (cg-RX-API-DMAC7.html)
JP2023084138A5 (cg-RX-API-DMAC7.html)